Randomized comparison of single dose of recombinant human IL-12 versus placebo for restoration of hematopoiesis and improved survival in rhesus monkeys exposed to lethal radiation

The Ability of Filgrastim to Mitigate Mortality Following LD50/60 Total-body Irradiation Is Administration Time-Dependent

(2013) Ann M. Farese et al.   HEALTH PHYSICS

HemaMax™, a Recombinant Human Interleukin-12, Is a Potent Mitigator of Acute Radiation Injury in Mice and Non-Human Primates

(2012) Lena A. Basile et al.   PLoS One

Filgrastim Improves Survival in Lethally Irradiated Nonhuman Primates

(2012) Ann M. Farese et al.   RADIATION RESEARCH

A review of radiation countermeasure work ongoing at the Armed Forces Radiobiology Research Institute

(2011) Vijay K. Singh et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Radiation victim management and the haematologist in the future: Time to revisit therapeutic guidelines?

(2010) Michel Drouet et al.   INTERNATIONAL JOURNAL OF RADIATION BIOLOGY

Animal Models for Medical Countermeasures to Radiation Exposure

(2010) Jacqueline P. Williams et al.   RADIATION RESEARCH

Radiation countermeasure agents: an update

(2009) Francis Dumont et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Multilineage hematopoietic recovery with concomitant antitumor effects using low dose Interleukin-12 in myelosuppressed tumor-bearing mice

(2008) Lena A Basile et al.   Journal of Translational Medicine